Hope & Histamine: The Paediatric Allergy Podcast

What’s new in childhood asthma care—and what does it mean for everyday practice?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore recent advances in paediatric asthma management, from inhaled treatments and personalised care to the evolving role of biologics in severe asthma.

We discuss key questions around asthma diagnosis, inhaler technique, treatment adherence and preventing exacerbations, alongside emerging approaches to help children achieve better asthma control.

Designed for paediatricians, GPs, nurses and other healthcare professionals caring for children with asthma, this episode brings an accessible clinical perspective to a rapidly changing field.

Source: 

Dhochak, N., Robinson, P.F.M. and Saglani, S. (2026) 'Update on Pediatric asthma management: Recent advances', Pediatric Allergy and Immunology, 37, e70480. doi: 10.1111/pai.70480.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

How does omalizumab compare with oral immunotherapy for treating multiple food allergies? In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore OUtMATCH Stage 2, comparing omalizumab (Xolair) with omalizumab-facilitated multi-allergen oral immunotherapy (OIT).

We unpack the findings on treatment success, allergic reactions, side effects and treatment discontinuation—and explain why tolerability matters when interpreting the results. What do these findings mean for children with peanut allergy and other food allergies, their families, and the clinicians supporting them?

Join us for an accessible, evidence-based discussion of anti-IgE therapy, food allergy desensitisation and personalised treatment decisions. Whether you’re a paediatrician, allergist, trainee or parent, discover what the OUtMATCH trial adds to the evolving conversation about multifood allergy treatment.

Sources:

1. Wood, R.A. et al. (2024) 'Omalizumab for the Treatment of Multiple Food Allergies', New England Journal of Medicine, 390(10), pp. 889–899. doi: 10.1056/NEJMoa2312382.
2. Wood, R.A. et al. (2026) 'Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy: A Randomized Clinical Trial', JAMA Pediatrics, Advance online publication. doi: 10.1001/jamapediatrics.2026.2910.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Can eating more eggs and peanuts during pregnancy and breastfeeding reduce a baby’s risk of developing food allergy?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we examine the PrEggNut trial, a large randomised study involving more than 2,100 pregnant women whose babies had a strong family history of allergic disease. Researchers compared a maternal diet rich in eggs and peanuts with a standard-intake diet from pregnancy until four months after birth.

Despite greater maternal exposure, the high-intake diet did not significantly reduce egg or peanut allergy in infants at one year of age. We explore the study’s findings, its strengths and limitations, and what the results mean for maternal diet, breastfeeding and current approaches to preventing food allergy in children.

A concise, evidence-based discussion for parents, paediatricians, allergy professionals and anyone interested in pregnancy nutrition and infant allergy prevention.

Source:

Palmer, D.J., Sullivan, T.R., Campbell, D.E., Netting, M.J., McWilliam, V., Perrett, K.P., Makrides, M., et al. (2026)'Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy', New England Journal of Medicine, 395(11), pp. 1090–1099. doi: 10.1056/NEJMoa2605659.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

What happens when a severe allergic reaction affects not only the skin and airways but also the coronary arteries?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore Kounis syndrome—an acute coronary syndrome triggered by an allergic or hypersensitivity reaction. We discuss how mast-cell activation and inflammatory mediators can cause coronary artery spasm, plaque disruption or stent thrombosis, resulting in symptoms that may resemble a heart attack alongside features of anaphylaxis.

Discover the common triggers, different clinical types, warning signs, diagnostic challenges and key management considerations. This episode also examines the delicate balance involved in treating anaphylaxis and cardiac ischaemia simultaneously.

An essential listen for paediatricians, allergists, emergency clinicians, cardiologists, trainees and anyone interested in the important connection between allergy and the heart.

Sources:

1. Anastasopoulou, M., Karanasos, A., Grafanaki, K., Almpanis, G., Koutsogiannis, N., Mplani, V., Papadionysiou, C., Kounis, N.G., Georgiou, S. and Davlouros, P. (2026) 'Incidence of Elevated Cardiac Biomarkers in Patients Presenting to the Emergency Department With Allergic Symptoms: Implications for the Diagnosis of Kounis Syndrome', The American Journal of Cardiology, 258, pp. 1–8. doi: 10.1016/j.amjcard.2025.08.036.
2. Ceasovschih, A., Kounis, N.G., Markos, S., Ejubovic, M., Cherska, M., Barkas, F., Ristovski, V., Corlateanu, A., Sivapalan, P., Kotlyarov, S., Sorodoc, V. and Sorodoc, L. (2026) 'Kounis Syndrome Features in Special Populations', Medical Sciences, MDPI, pp. 1–20.
3. Foti Randazzese, S., Caminiti, L., Crisafulli, G., Giovannini, M., Kounis, N.G. and Manti, S. (2024) 'Kounis syndrome in an adolescent with lipid transfer protein allergy', Pediatric Allergy and Immunology, 35, p. e14239. doi: 10.1111/pai.14239.
4. Kalambay, J.D., Tashli, M., Zaman, M., Elwidaa, A., Shet, V. and Phillip, M. (2026) 'Kounis Syndrome: A Systematic Review and Meta-analysis', The American Journal of Cardiology, 268, pp. 25–31. doi: 10.1016/j.amjcard.2026.03.019.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help improve awareness of hereditary angioedema and advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Is it time to rethink the traditional blue reliever inhaler for children with mild asthma?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we examine the landmark 2025 CARE trial published in The Lancet. This 52-week randomised controlled trial compared budesonide–formoterol with salbutamol as reliever therapy in children with mild asthma.

We explore whether an anti-inflammatory reliever inhaler can provide better protection than salbutamol alone, examining the trial’s findings on asthma attacks, symptom control, safety and treatment burden. We also consider what the results could mean for paediatric asthma guidelines, clinical practice and conversations with children and their families.

Whether you are a paediatrician, GP, nurse, pharmacist, trainee or parent, this episode offers a clear and clinically relevant discussion of a study that could reshape how mild childhood asthma is managed.

Listen now to discover whether budesonide–formoterol could represent the future of reliever therapy for children with mild asthma.

Source:

Hatter, L., Holliday, M., Oldfield, K., Kearns, C., Barry, T., Black, M., Bruce, P., Colman, A., Dickinson, E., Eathorne, A., Harwood, M., Hills, T., Lamb, R., Kerse, K., Krishnamoorthy, S., Martindale, J., Semprini, A., Shortt, N., McNamara, D., Byrnes, C.A., Dalziel, S.R., Bush, A., Weatherall, M. and Beasley, R., 2025.Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial. The Lancet, 406, pp. 1473–1483. Available at: https://doi.org/10.1016/S0140-6736(25)00861-X.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help improve awareness of hereditary angioedema and advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Could a simple skin patch transform the treatment of peanut allergy in young children?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the latest evidence on epicutaneous immunotherapy (EPIT)—also known as the peanut patch—for toddlers and children with peanut allergy.

Drawing on findings from the EPITOPE and EPOPEX studies, we examine how peanut patch therapy works, its long-term effectiveness and safety, and whether it can increase the amount of peanut a child can tolerate. We also discuss its potential to reduce the risk of allergic reactions from accidental exposure to packaged foods and consider how well EPIT works in children who also have atopic conditions such as eczema, asthma and allergic rhinitis.

Can epicutaneous immunotherapy offer families meaningful protection while avoiding some of the challenges associated with oral immunotherapy? Could the peanut patch become part of routine childhood peanut allergy treatment?

Join us as we translate the emerging research into clear, practical information for parents, clinicians and everyone interested in the future of paediatric food allergy care.

Sources:

1. Burks, A., Sindher, S., Wang, J., O'Sullivan, M., Du Toit, G., Kim, E., Bois, T. and Greenhawt, M., 2022. EPITOPE study results: Phase 3, randomized, double-blind, placebo-controlled study of epicutaneous immunotherapy in peanut-allergic toddlers [Abstract]. Annals of Allergy, Asthma & Immunology, 129(5 Supplement), p. S12.
2. Greenhawt, M., Wang, J., DuToit, G., O’Sullivan, M., Brown-Whitehorn, T., Bois, T., Bee, K., Green, T., Sampson, H. and Burks, A., 2025. Long-term efficacy and safety of epicutaneous immunotherapy in peanut-allergic toddlers: EPOPEX end of study results [Abstract]. Annals of Allergy, Asthma & Immunology, 135(5 Supplement), p. S10. 
3. Remington, B.C., Krone, T., Kim, E.H., Bird, J.A., Green, T.D., Lack, G., Fleischer, D.M. and Koppelman, S.J., 2019. Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy. Annals of Allergy, Asthma & Immunology, 123(5), pp. 488-493. 
4. Scurlock, A.M., Fleischer, D.M., Du Toit, G., Arends, N.J.T., Pongracic, J.A., Trujillo, J., Turner, P., Vogelberg, C., Bee, K.J., Green, T.D., Meney, J., Bois, T., Campbell, D.E., Sampson, H.A. and Burks, A.W., 2025. Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities. Annals of Allergy, Asthma & Immunology, 135(2), pp. 203-210.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Dupilumab has transformed the treatment of several type 2 inflammatory conditions—but how does it work, which children may benefit, and what should clinicians and families know before starting treatment?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the expanding role of dupilumab in paediatrics, including its use in atopic dermatitis (eczema), severe asthma and eosinophilic oesophagitis. We discuss how blocking interleukin-4 and interleukin-13 signalling helps control allergic inflammation, along with patient selection, administration, monitoring, potential adverse effects, and the practical considerations of biologic treatment.

Whether you are a paediatrician, allergy specialist, healthcare professional, or parent, this episode provides a clear, clinically relevant introduction to how dupilumab is reshaping the management of childhood atopic disease.

Sources:

1. Foti Randazzese, S., Calamita, A., D’Angelo, D., Marseglia, A., Mesa Lombardero, E., Pedersoli, S., Tedeschi, M., De Amici, M., Manti, S., Brazzelli, V., Licari, A. and Marseglia, G.L. (2026) 'Emerging Paediatric Uses of Dupilumab Beyond Approvals', Clinical & Experimental Allergy. Available at: https://doi.org/10.1111/cea.70381.
2. Gutsche, A., Grabowska, W., Altrichter, S., Grekowitz, E., Roll, S., Heine, G., Staubach, P., Pfützner, W., Brehler, R., Bauer, A., Wagner, N., Wurpts, G., Salameh, P., Salehzadeh-Yazdi, A., Jahandideh, S.S. and Metz, M. (2026) 'Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study', Allergy. Available at: https://doi.org/10.1111/all.70454.
3. Lasek, A., Bellon, N., Mallet, S., Aubert, H., Vera, C., Achour, L., Thénié, C., Prescilla, R., Abasq-Thomas, C. and Barbarot, S. (2026) 'Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis', Journal of the European Academy of Dermatology and Venereology, 40, pp. 1208–1217. Available at: https://doi.org/10.1111/jdv.70268.
4. Wechsler, M.E., Wenzel, S.E., Groshong, S.D., Castro, M., Pavord, I.D., Rabe, K.F., Laws, E., Jagerschmidt, A., Gayvert, K., Harel, S., Hamilton, J.D., Amin, N., Zhang, L., Xing, H., Elfakir, A., Coulibaly, B., Naimi, S., Hamon, S., Rowe, P.J., Nestle, F., Cunoosamy, D.M., de Rinaldis, E. and Mannent, L.P. (2026) 'Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma', Allergy. Available at: https://doi.org/10.1111/all.70391.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Hereditary angioedema (HAE) is a rare but potentially life-threatening genetic disorder that often presents during childhood, yet diagnosis is frequently delayed for many years. Early recognition and timely treatment can dramatically improve quality of life and reduce the risk of serious complications, including airway obstruction.

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the latest evidence and practical approaches to diagnosing and managing paediatric hereditary angioedema (HAE). Whether you’re a paediatrician, allergy specialist, emergency clinician, trainee, nurse, or allied healthcare professional, this episode provides a comprehensive overview of this important condition.

In this episode, we discuss:

• Understanding the genetics and pathophysiology of hereditary angioedema
• Clinical features that distinguish HAE from allergic angioedema
• Common triggers and patterns of attacks in children
• Diagnostic investigations, including complement testing and genetic confirmation
• Recognising red flags for life-threatening laryngeal oedema
• Acute management of HAE attacks
• Short-term and long-term prophylactic treatment options
• The role of C1 esterase inhibitor replacement therapy, bradykinin-targeted treatments and emerging therapies
• Family screening, genetic counselling and transition to adult services
• Practical tips for emergency action plans and improving patient outcomes

Join us as we review current guidelines, discuss real-world clinical challenges, and share practical insights to help clinicians recognise hereditary angioedema earlier and deliver evidence-based care for children and young people living with HAE.

Source:

Farkas, H. et al. (2026) 'International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema', Allergy. Available at: https://onlinelibrary.wiley.com/doi/10.1111/all.70207. DOI: 10.1111/all.70207.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Hope & Histamine: The Paediatric Allergy Podcast brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.

🎧 Listen and subscribe:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help improve awareness of hereditary angioedema and advance the care of children with rare allergic and immunological conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Why do your ears feel blocked during allergy season? Can hay fever really affect your hearing? What causes that frustrating sensation of ear fullness, popping, crackling or pressure that just won’t go away?

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore the important relationship between allergic disease and Eustachian Tube Dysfunction (ETD)—a common but often misunderstood condition affecting both children and adults.

Join us as we discuss:

• What the Eustachian tube is and why it is essential for normal ear function.
• How allergic rhinitis, environmental allergies and nasal inflammation contribute to Eustachian Tube Dysfunction.
• The common symptoms of ETD, including ear fullness, pressure, popping, crackling, muffled hearing, tinnitus and discomfort during flying or altitude changes.
• How ETD differs from ear infections, glue ear and other causes of hearing problems.
• The role of allergy testing and ENT assessment in making an accurate diagnosis.
• Evidence-based treatments, including allergen avoidance, intranasal corticosteroids, antihistamines, saline nasal irrigation and when specialist ENT interventions may be appropriate.
• Practical self-care strategies for managing symptoms at home.
• When persistent ear symptoms require urgent medical assessment.

Whether you’re a parent, patient, allergy sufferer, healthcare professional or simply curious about the connection between allergies and ear health, this episode provides clear, evidence-based guidance to help you better understand and manage Eustachian Tube Dysfunction.

Source: 

Klimek, L. et al. (2025) 'Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity—An EAACI Position Paper', Allergy. doi: 10.1111/all.16554.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

Subscribe to Hope & Histamine for expert discussions on paediatric allergy, immunology and related conditions, featuring the latest research and practical advice from specialists.

🎧 Listen on your favourite podcast platform or visit:
https://hopeandhistaminepodcasts.buzzsprout.com

If you enjoy the podcast, please subscribe, leave a review and share this episode to help others learn more about allergy-related conditions.

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay. 

Orofacial Granulomatosis (OFG) is a rare but often overlooked inflammatory condition that can present with persistent lip swelling, oral ulcers, gum changes, and facial swelling. Because its symptoms overlap with many other conditions, diagnosis is frequently delayed, leaving patients and families searching for answers.

In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we take a deep dive into the science and clinical management of Orofacial Granulomatosis. We discuss what OFG is, why it develops, and its important associations with Crohn’s disease, allergy, and other inflammatory disorders. You’ll learn how clinicians approach the diagnosis, the role of biopsies and investigations, and the latest evidence-based treatment options available for both children and adults.

Whether you’re a healthcare professional, medical student, patient, or parent, this episode provides a clear, practical, and evidence-based overview of this fascinating condition.

In this episode, we cover:

• What is Orofacial Granulomatosis (OFG)?
• Common signs and symptoms, including persistent lip swelling
• Causes and current theories behind OFG
• The relationship between OFG and Crohn’s disease
• Is allergy involved?
• How OFG is diagnosed and the role of biopsy
• Important differential diagnoses clinicians should consider
• Medical and dietary treatment options
• Long-term outlook and follow-up
• Key take-home messages for patients, families, and healthcare professionals

Join us as we separate fact from fiction and explore the latest understanding of Orofacial Granulomatosis, helping listeners recognise the condition earlier and understand the best approaches to diagnosis and management.

Sources:

1. Courtney, A., Holmes, Z., Sharma, S. and Brand, R., 2023. Orofacial granulomatosis: Challenges in diagnosis and treatment. Journal of Paediatrics and Child Health, 59, pp. 159-161.
2. Galdiero, M.R., Maio, F., Arcoleo, F., Boni, E., Bonzano, L., Brussino, L., Cancian, M., Cremonte, L., Del Giacco, S.R., De Paulis, A., Detoraki, A., Firinu, D., Lamacchia, D., Loffredo, S., Nettis, E., Parente, R., Parronchi, P., Pellacani, G., Petraroli, A., Rolla, G., Senter, R., Triggiani, M., Vitiello, G., Spadaro, G. and Bova, M., 2021. Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature. Allergy, 76(7), pp. 2189-2200.
3. Haaramo, A., Alapulli, H., Aine, L., Saarnisto, U., Tuokkola, J., Ruuska, T., Sipponen, T., Pitkäranta, A. and Kolho, K.L., 2017. Detailed Follow-up Study of Pediatric Orofacial Granulomatosis Patients. Journal of Pediatric Gastroenterology and Nutrition, 65(4), pp. 388-393.
4. Marttala, A., Sihvonen, E., Kantola, S., Ylöstalo, P. and Tervonen, T., 2018. Diagnosis and Treatment of Orofacial Granulomatosis. Journal of Dentistry for Children, 85(2), pp. 83-87.
5. Pathania, Y.S., 2022. Current treatment modalities in granulomatous cheilitis. International Journal of Dermatology, 61, pp. 755-759.
6. Sahni, V.N., Yim, R., Amanullah, A., Sahni, D., Powell, D., deShazo, R., Rhoads, J.L.W., Clarke, J.T., Hansen, C.B., Zone, J.J., Hull, C.M. and Hopkins, Z.H., 2026. An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review. Dermatitis, 37(1), pp. 13-19.

🎧 Listen now on Apple Podcasts, Spotify, Amazon Music, and YouTube

Disclaimer: The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.

Buy me a coffee: https://coff.ee/goodlifecreations

🎧 Subscribe to Hope & Histamine: The Paediatric Allergy Podcast for expert discussions on paediatric allergy, immunology, and related conditions. New episodes feature practical, evidence-based insights from leading specialists, designed for clinicians, patients, and families alike.

🌐 Podcast website: https://hopeandhistaminepodcasts.buzzsprout.com

Send us Fan Mail

Support the show

Brought to you by - Goodlife Creations (2026). 

Music by - Denys Kyshchuk from Pixabay.